Therapeutic potential of anti-HIV immunotoxins
- 1 October 1996
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 33 (1), 1-9
- https://doi.org/10.1016/s0166-3542(96)00995-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- In VitroEffects of Anti-HIV Immunotoxins Directed against Multiple Epitopes on HIV Type 1 Envelope Glycoprotein 160AIDS Research and Human Retroviruses, 1996
- Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and ZalcitabineNew England Journal of Medicine, 1996
- Immunotoxins: An UpdateAnnual Review of Immunology, 1996
- Expression and Characterization of CD4-IgG2, a Novel Heterotetramer That Neutralizes Primary HIV Type 1 IsolatesAIDS Research and Human Retroviruses, 1995
- Continuous Presence of CD4-PE40 Is Required for Antiviral Activity Against Single-Passage HIV Isolates and Infected Peripheral Blood Mononuclear CellsAIDS Research and Human Retroviruses, 1993
- Effects of administration of an anti‐cd5 plus immunoconjugate in rheumatoid arthritis. results of two phase ii studiesArthritis & Rheumatism, 1993
- CD4-Pseudomonas exotoxin conjugates delay but do not fully inhibit human immunodeficiency virus replication in lymphocytes in vitro.Journal of Clinical Investigation, 1990
- Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodiesNature, 1990
- Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.The Journal of Experimental Medicine, 1990
- Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid proteinNature, 1988